Aaron Wang, PharmD candidate

home / authors / aaron-wang-pharmd-candidate

Articles

Addressing HIV with Incarcerated Individuals Requires Understanding of PrEP

Addressing HIV with Incarcerated Individuals Requires Understanding of PrEP

Aaron Wang, PharmD candidate
April 1st 2020

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.

Read More

Study: Pharmacy Students Receive More Education about PrEP than Other Disciplines

Study: Pharmacy Students Receive More Education about PrEP than Other Disciplines

Aaron Wang, PharmD candidate
March 26th 2020

Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.

Read More

Increasing HIV Pre-exposure Prophylaxis in the Homeless Requires Effort

Increasing HIV Pre-exposure Prophylaxis in the Homeless Requires Effort

Aaron Wang, PharmD candidate
March 23rd 2020

Only 15% of those at risk are currently using PrEP.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD